CYP 0.00% 19.5¢ cynata therapeutics limited

"The iPSC technology was pioneered by Shinya Yamanaka and...

  1. 4,035 Posts.
    lightbulb Created with Sketch. 298

    "The iPSC technology was pioneered by Shinya Yamanaka and Kazutoshi Takahashi in Kyoto, Japan, who together showed in 2006 that the introduction of four specific genes (named Myc, Oct3/4, Sox2 and Klf4), collectively known as Yamanaka factors, encoding transcriptionfactors could convert somatic cells into pluripotent stem cells

    The overexpression of Oct3/4, Sox2, Klf4 and/or c-Myc could contribute to the pathologica lself-renewal characteristics of cancer stem cells.

    Cancer stem cells can originate from mutation in normal somatic stem cells that deregulate their physiological programs. Alternatively, mutations may target more committed progenitor cells or even mature cells, which become reprogrammed to acquire stem-like functions."

    Oh Dear

    Last edited by gavint66: 04/06/24
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $35.20M
Open High Low Value Volume
19.5¢ 19.5¢ 19.0¢ $5.809K 29.86K

Buyers (Bids)

No. Vol. Price($)
1 48825 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 10000 1
View Market Depth
Last trade - 15.21pm 07/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.